Third Quarter of Fiscal Year Ending Mar. 2020
- Key metrics (PDF / 148KB)
- Composition of Capital Disclosure (PDF / 235KB)
- Reconciliation of regulatory capital elements back to the balance sheet (PDF / 86KB)
- Overview of RWA (PDF / 85KB)
- RWA flow statements of credit risk exposures under IRB (PDF / 27KB)
- RWA flow statements of market risk exposures under IMA (PDF / 20KB)
- Composition of Leverage Ratio (PDF / 236KB)
- Liquidity Coverage Ratio (PDF / 29KB)
- Main features of regulatory capital instruments
Regulatory capital instruments (TLAC eligible)
Eligible capital instruments under transitional treatment (not TLAC eligible (note))
- Can be counted in external and internal TLAC by 2022/3/30 as FSB's transitional treatment